News

Find News

Filter articles

Applied Filters

Showing 41 to 50 of 225 results

Sun Pharma unit bolsters patent suit with trade secrets claims

India, US12-07-2018

Dusa Pharmaceuticals, a subsidiary of India-based generic drug maker Sun Pharma, has accused dermatology-focused company Biofrontera of misappropriating trade secrets.

US tariffs on med tech prevent patient access: trade association

China, US09-07-2018

A medical technology trade association has warned that the US tariffs recently implemented in response to Chinese IP theft may hinder patient access to life-saving technologies.

US leading the way in patent filings for applications of synthetic biology: PatSnap

China, US28-06-2018

The US is leading the way in synthetic biology patent filings, according to a report released earlier this month from patent search software company PatSnap.

MSF challenges Gilead patent in China

China20-06-2018

Humanitarian organisation Médecins Sans Frontières has challenged a patent owned by Gilead in China.

Sage Therapeutics and Shionogi partner to develop antidepressant

15-06-2018

US-based biopharmaceutical company Sage Therapeutics and Japan-based pharmaceutical corporation Shionogi have entered into a strategic collaboration to develop an antidepressant drug.

India launches project to help consumers identify counterfeit drugs via text message

India04-06-2018

India’s Drug Technical Advisory Board, which advises the government, has reportedly approved a “track and trace” proposal that will allow Indian consumers to identify whether their medicine is genuine simply by sending a text message.

Celgene drops trademark claim against online pharmacies

India, US10-05-2018

Biopharmaceutical company Celgene has ditched its trademark quarrel with the owners of India-based online pharmacies importing generics into the US.

India’s Supreme Court refuses to stay Monsanto patent order

India08-05-2018

India’s Supreme Court has refused to stay an order which held that agricultural company Monsanto’s patent on genetically modified cotton seeds is invalid.

Chugai abandons patent claim against Nippon Kayaku

Japan12-04-2018

Japan-based Chugai Pharmaceuticals has announced it has withdrawn its patent infringement claim against generic anti-cancer business Nippon Kayaku.

Monsanto suffers patent loss in India

India12-04-2018

Agriculture company Monsanto suffered a loss in India yesterday when the High Court of Delhi concluded that the company’s patent on genetically modified cotton seeds is not valid.

Showing 41 to 50 of 225 results

LSIPR